CraniUS LLC (Baltimore, MD, USA; www.craniusmed.com) has developed a groundbreaking solution to overcome the blocking of drugs by the blood-brain barrier.

The company’s implantable drug delivery devece,NeuroPASS,  is capable of circumventing the blood-brain barrier and could revolutionize the treatment of a range of brain-related conditions.

NeuroPASS is the world’s first fully implantable, wireless medical device that enables chronic and direct medicine delivery to the brain.

It is easily refillable, rechargeable from a distance, and can remain unnoticed under the skin in the skull.

The device is versatile, with applications for a variety of brain-related conditions including neurodegenerative diseases and brain tumors.